Phase I/IIa trial of AT-001 (dnaJP1) in the patients with Rheumatoid-arthritis.
Phase of Trial: Phase I/II
Latest Information Update: 08 Feb 2018
At a glance
- Drugs DnaJP1 (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- 08 Feb 2018 New trial record
- 14 May 2004 According to an Androclus Therapeutics media release, data were published in Proceedings of the National Academy of Sciences.